Carlos Campoy Cytom X Therapeutics, Inc. (CTMX) insider trading activity

CTMX Quotes by TradingView

Carlos Campoy is Chief Financial Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 38,224 shares of CTMX, which is worth approximately $51,602. The most recent transaction as insider was on Mar 16, 2023, when has been sold 1,748 shares (Common Stock) at a price of $1.98 per share, resulting in proceeds of $3,461. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.2K
0% 3M change
0% 12M change
Total Value Held $51,602

Carlos Campoy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2023
SELL
Open market or private sale
$3,461 $1.98 p/Share
1,748 Reduced 4.37%
38,224 Common Stock
Jul 20 2022
SELL
Open market or private sale
$5,608 $1.42 p/Share
3,949 Reduced 8.99%
39,972 Common Stock
Jul 19 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 25.46%
43,921 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
22,500 Added 43.76%
28,921 Common Stock
May 31 2021
BUY
Grant, award, or other acquisition
$20,219 $6.09 p/Share
3,320 Added 34.08%
6,421 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$19,815 $6.39 p/Share
3,101 Added 50.0%
3,101 Common Stock

Also insider at

ZYME
Zymeworks Inc.
CC

Carlos Campoy

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on CTMX

Follow CytomX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

News

Receive news related to CytomX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTMX